ProfileGDS4718 / 223006_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 79% 94% 82% 80% 84% 81% 80% 83% 80% 79% 83% 73% 81% 81% 85% 84% 82% 80% 77% 80% 84% 83% 84% 84% 81% 87% 84% 84% 83% 83% 84% 77% 84% 81% 83% 86% 79% 82% 93% 80% 86% 83% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7186479
GSM549102patient 115, normal, homogenized [OPG study]7.7274479
GSM549104patient 119, normal, homogenized [OPG study]10.06994
GSM549108patient 138, normal, homogenized [OPG study]7.9520982
GSM549119patient 077, normal, homogenized [OPG study]7.7572280
GSM549133patient 032, cancer, homogenized [OPG study]8.4803384
GSM549139patient 042, cancer, homogenized [OPG study]7.9739581
GSM549099patient 107, normal, homogenized [OPG study]7.7167280
GSM549109patient 139, normal, homogenized [OPG study]8.2026583
GSM549110patient 046, normal, homogenized [OPG study]7.8266980
GSM549114patient 063, normal, homogenized [OPG study]7.786879
GSM549122patient 082, normal, homogenized [OPG study]8.2306683
GSM549134patient 033, cancer, homogenized [OPG study]7.1839173
GSM549136patient 036, cancer, homogenized [OPG study]8.1139281
GSM549140patient 044, cancer, homogenized [OPG study]8.1095881
GSM549111patient 047, normal, homogenized [OPG study]8.4967685
GSM549113patient 057, normal, homogenized [OPG study]8.5189984
GSM549132patient 031, cancer, homogenized [OPG study]8.0793982
GSM549137patient 038, cancer, homogenized [OPG study]7.9510580
GSM549142patient 047, cancer, homogenized [OPG study]7.3758377
GSM549100patient 110, normal, homogenized [OPG study]7.7219380
GSM549107patient 135, normal, homogenized [OPG study]8.4246484
GSM549115patient 068, normal, homogenized [OPG study]8.3145683
GSM549116patient 072, normal, homogenized [OPG study]8.3818684
GSM549120patient 078, normal, homogenized [OPG study]8.3916684
GSM549131patient 030, cancer, homogenized [OPG study]8.1394281
GSM549118patient 074, normal, homogenized [OPG study]8.8620987
GSM549129patient 027, cancer, homogenized [OPG study]8.3632984
GSM549123patient 088, normal, homogenized [OPG study]8.348784
GSM549124patient 006, cancer, homogenized [OPG study]8.1324183
GSM549126patient 015, cancer, homogenized [OPG study]8.2375683
GSM549128patient 025, cancer, homogenized [OPG study]8.3783584
GSM549103patient 117, normal, homogenized [OPG study]7.4088777
GSM549117patient 073, normal, homogenized [OPG study]8.4552984
GSM549138patient 041, cancer, homogenized [OPG study]8.0559981
GSM549141patient 045, cancer, homogenized [OPG study]8.3230983
GSM549130patient 028, cancer, homogenized [OPG study]8.5579786
GSM549101patient 111, normal, homogenized [OPG study]7.7249279
GSM549105patient 128, normal, homogenized [OPG study]8.0570282
GSM549106patient 134, normal, homogenized [OPG study]9.8487193
GSM549112patient 048, normal, homogenized [OPG study]7.8990280
GSM549125patient 011, cancer, homogenized [OPG study]8.5956486
GSM549127patient 024, cancer, homogenized [OPG study]8.2120483
GSM549135patient 035, cancer, homogenized [OPG study]7.9880780